Discovery of First-in-Class hCA II/ROCK Dual Inhibitors with Both IOP-Lowering and Retinal Neuroprotective Activities for the Treatment of Glaucoma
Year: 2026
Type: article
Source: Journal of Medicinal Chemistry
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1110839213, G3251980028, G450242269, G61470557
OpenAlex ID: W7237215871
